Evofem Biosciences Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Corporate Update

Go back to Evofem Biosciences Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Corporate Update

Evofem Biosciences (EVFM) Tops Q4 EPS by 2c

March 12, 2020 8:04 AM EDT

Evofem Biosciences (NASDAQ: EVFM) reported Q4 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29).

"The Evofem team's exceptional execution in 2019 laid the groundwork for what will be a transformative year for the Company," said Saundra Pelletier, Chief Executive Officer, Evofem Biosciences. "We are... More